Treating HCC with genetically modified NK-cell therapy
Blocking the TGF-β signalling pathway produced effective antitumour activity against hepatocellular carcinoma.
List view / Grid view
Blocking the TGF-β signalling pathway produced effective antitumour activity against hepatocellular carcinoma.
Thousands of bile acids have been discovered, providing new insights into how microbes influence distant organ systems.
US researchers use genome sequencing to reveal genetic basis for disabling pansclerotic morphea, a severe inflammatory disease.
Researchers have found a potential therapeutic target less vulnerable to potential drug resistance and emerging COVID-19 variants of concern.
Researchers in the US have developed a new CRISPR method for treating genetic conditions using nickases that they say is safer and more effective.
In this article, Dr Jim Burns discusses promising pre-clinical results of how a new platform could treat the root cause of many devastating genetic diseases including myotonic dystrophy type 1.